Israeli medical cannabis firms aim for new high

Israel is attracting international investors as it positions itself as a cutting-edge exporter for medical-grade cannabis to a global market that could reach $50 billion by 2025. David Pollard reports.

Subscribe: http://smarturl.it/reuterssubscribe
More updates and breaking news: http://smarturl.it/BreakingNews

Reuters tells the world's stories like no one else. As the largest international multimedia news provider, Reuters provides coverage around the globe and across topics including business, financial, national, and international news. For over 160 years, Reuters has maintained its reputation for speed, accuracy, and impact while providing exclusives, incisive commentary and forward-looking analysis.

http://reuters.com/
https://www.facebook.com/Reuters
https://plus.google.com/u/0/s/reuters
https://twitter.com/Reuters